Postmarketing Adverse Drug Experience Pade Inspections 1of3 Jun 19 2018

Summary

Hector Colon from FDA's Office of Regulatory Affairs provides an overview of bioresearch monitoring program (BIMO) Namita Kothary from CDER's Division of Enforcement and Peter Diak and Haley Seymour from FDA's REMS compliance team provides an overview of the REMS program to help applicants ... FDA provides a regulatory foundation related to To learn more: xtalks.com/regulatory-compliance-FDA- Howard Chazin, MD, MBA, Director of the Clinical Safety Surveillance Staff, discusses generic Mary Denigan-Macauley discusses our February 2022 report on the Federal In this session, we cover PADER (Periodic Laurie Graham, Director for the Division of Internal Policies and Procedures, discusses site CDRH's Kimberly Kontson and CDER's Quynh Nhu Nguyen provide an overview of human factors in medical products, human ... The second installment of our two-part, in-depth look at the changing world of FDA An upbeat, creative, and informative overview that outlines the advantages of working at the FDA's Center for